FDA advisory panel: asthma drugs should stay on market
An FDA advisory panel Wednesday voted unanimously in favor of continued marketing by GlaxoSmithKline and Novartis of three long-acting beta-agonist ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.